Our Impact at a Glance
What we achieved in 2021-2022:
200+
Portfolio trials supported
6230+
Patients recruited to portfolio trials
130+
Percent increase in patients above the pre-3CTN baseline
Stay Connected
Social Media
News
Events
G.A.P.P: Overcoming Staffing Challenges at Trials Units
3CTN is excited to announce that the upcoming G.A.P.P Webinar: Overcom…
impACCT Virtual Rounds Winter Session 2023
The Canadian Cancer Clinical Trials Network (3CTN) is pleased to annou…